Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response
Titel:
Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response
Auteur:
Stein, J.E. Soni, A. Danilova, L. Cottrell, T.R. Gajewski, T.F. Hodi, F.S. Bhatia, S. Urba, W.J. Sharfman, W.H. Wind-Rotolo, M. Edwards, R. Lipson, E.J. Taube, J.M.